Dashboard
Financial statements
DHR

Company financials

Danaher Corporation

Health Care Life Sciences Tools & Services Washington, D.C. Last filing Feb 24, 2026 · FY2025
Revenue FY2025
$24.6B
3y CAGR -2.7% P10
Net income FY2025
$3.6B
Net margin +14.7% P65
Total assets FY2025
$83.5B
ROA +4.3% P37
Operating cash flow FY2025
$6.4B
FCF margin +21.4% P78
19 yrs · FY2007–FY2025 8 filed · 1 derived · 0 blank

Year-over-year change per cell; first column has no prior.

Balance Sheet

Assets, liabilities, and equity

29 accounts · 5 years
Total assets $83.5B
Total liabilities ~$30.9B
Shareholders equity $52.5B
Account 2025 2024 2023 2022 2021 Trend
Assets
Cash and Cash Equivalents +122.1% -64.6% -2.2% +131.8%
Short Term Investments
Accounts Receivable +10.6% -9.8% -20.3% +6.2%
Inventory +6.8% -10.2% -16.6% +12.4%
Prepaid Expenses +12.0% -0.3% -16.3% +11.8%
Other Current Assets +5.5% +9.5% -18.3% +19.9%
Total Current Assets +34.3% -31.9% -12.3% +36.4%
Property,Plant and Equipment +10.8% +9.6% +22.8% -2.1%
Operating Lease Assets +12.0% +3.0% +5.1% -3.8%
Goodwill +6.6% -2.7% +11.6% -9.5%
Intangible Assets -4.0% -10.5% +2.2% -11.1%
Other Noncurrent Assets +5.5% +9.5% -18.3% +19.9%
Total Assets +7.6% -8.2% +0.2% +1.4%
Liabilities
Accounts Payable +5.2% -0.7% -23.1% -10.6%
Accrued Liabilities +9.3% -5.7% -12.5% -1.1%
Current Portion of Long Term Debt -99.6% -70.2% +186.8% +7287.5%
Other Current Liabilities +0.1% -5.4% -11.3% -11.9%
Total Current Liabilities +0.1% -17.8% -1.4% +3.1%
Long Term Debt +18.8% -7.2% -12.5% -13.9%
Other Noncurrent Liabilities +0.1% -5.4% -11.3% -11.9%
Equity
Preferred Stock -100.0% -49.0%
Common Stock +0.0% +0.0% +0.0% +0.0%
Additional Paid In Capital +2.8% +18.2% +17.2% +19.6%
Retained Earnings +6.1% +7.6% +4.8% +19.4%
Treasury Stock +39.1%
Accumulated Other Comprehensive Income +93.6% -84.1% +39.1% -179.6%
Noncontrolling Interest +0.0% +75.0% -50.0% -20.0%
Total Stockholders Equity +6.0% -7.4% +6.8% +10.9%
Total Liabilitiesand Equity +7.6% -8.2% +0.2% +1.4%

Key Ratios

Margins, returns, liquidity, leverage, efficiency

Computed at import · 5 years
Ratio 2025 2024 2023 2022 2021
Profitability
Gross margin +59.1% +59.5% +58.7% +60.8% +61.4%
Operating margin +19.1% +20.4% +21.8% +28.3% +25.7%
Net margin +14.7% +16.3% +19.9% +27.1% +25.9%
FCF margin +21.4% +22.2% +24.2% +27.8% +28.7%
Growth
Revenue CAGR (3y) -2.7% -1.3% +2.3% +14.2% +13.3%
Returns
ROE +6.9% +7.9% +8.9% +14.4% +14.2%
ROA +4.3% +5.0% +5.6% +8.5% +7.7%
ROIC +6.0% +6.4% +6.6% +10.5% +8.2%
Liquidity
Current ratio 1.87x 1.40x 1.68x 1.89x 1.43x
Quick ratio 1.25x 0.83x 1.18x 1.30x 0.89x
Leverage
D/E 0.59x 0.57x 0.58x 0.68x 0.84x
Interest coverage 17.70x 17.49x 18.19x 36.94x 27.61x
Efficiency
Asset turnover 0.29x 0.31x 0.28x 0.32x 0.30x
Cash conversion cycle +82d +76d +91d +96d +76d

Valuation

Price against fundamentals

FY2025 fundamentals · no price

No price data cached, so there is nothing to multiply. Load prices from the Stock Data tab and this panel reprices itself.

Notes

Your annotations

Not watched
Saving notes adds DHR to your watchlist.